Rory Riggs, primary headshot

About Rory Riggs

Rory Riggs is an executive, entrepreneur, and inventor who developed the Locus Model and the Functional Information System (FIS), a coordinate structure for organizing and classifying information by function across biotechnology, finance, and economics.

Mr. Riggs is a co-founder and former Chairman of Royalty Pharma, where he helped establish the pharmaceutical royalty asset class. He is the founder and Executive Chairman of Syntax, whose FIS-based database for the securities industry is used by many of the world’s largest financial institutions.

He has been a founder, early investor, executive, or director of several publicly traded biotechnology companies, including Sugen, FibroGen, Cibus, Intra-Cellular Therapies, and Biomatrix, where, as President, he launched Synvisc, the product that established and is the leader in the viscosupplementation category for osteoarthritis of the knee. He was previously a Managing Director at PaineWebber and CEO of RF&P, a real estate investment company owned by the Virginia State Retirement System.

He is a director of the Feinstein Institute, the research arm of Northwell, and of the New York Genome Center. He is a graduate of Middlebury College and Columbia University.

Board and governance record

Current

  • Syntax Data — Executive Chairman and Founder
  • Cibus Inc. (CBUS) — Chairman of the Board
  • Scientia Ventures LLC — General Partner and Co-Founder
  • New York Genome Center — Director
  • Feinstein Institute (the research arm of Northwell) — Director
  • WEBs ETF Trust — CEO and Trustee, since 2017

Former

  • Royalty Pharma plc (RPRX) — Founder, 1996; Chairman, 2003–2024
  • Intra-Cellular Therapies Inc. (ITCI) — Director, 2014–2025
  • FibroGen Inc. (FGEN) — Co-Founder and Director, since October 1993
  • SUGEN Inc. — Founder or Early-Stage Investor, and Director
  • BioMatrix — Founder or Early-Stage Investor, and Director
  • PaineWebber — Managing Director
  • RF&P — Chief Executive Officer (real estate investment company owned by the Virginia State Retirement System)

Founding history

Across thirty years, the pattern repeats: identify a domain where the right system does not yet exist, then build it. Royalty Pharma (1996) built the market for pharmaceutical royalties as an asset class. FibroGen (1993), SUGEN, and BioMatrix applied the same discipline to drug development. Syntax Data built the coordinate system and its commercial applications for financial and economic data. Cibus applies pharmaceutical-grade production standards to plant biology through precision gene editing.

More on Rory

Career Timeline

Forty-five years, chronologically.

Credentials

Education, professional record, and recognition.

Patents

The full patent record behind the Locus Model.

Author & Social Profiles

Published writing, interviews, and professional profiles.

Media Kit

Headshot, short and long bios, and fast facts.

FAQ

Answers on the Locus Model, his companies, patents, and how to work with him.

Get in touch

For speaking, consulting, academic collaboration, or venture inquiries, see Systems Economics and Applications, or go directly to Contact.

Scroll to Top